Search hospitals > California > San Francisco
UCSF Medical Center-Mission Bay
Claim this profileSan Francisco, California 94158
Global Leader in Cancer
Global Leader in Tumors
Conducts research for Recurrence
Conducts research for Lymphoma
Conducts research for Brain Tumor
382 reported clinical trials
46 medical researchers
Summary
UCSF Medical Center-Mission Bay is a medical facility located in San Francisco, California. This center is recognized for care of Cancer, Tumors, Recurrence, Lymphoma, Brain Tumor and other specialties. UCSF Medical Center-Mission Bay is involved with conducting 382 clinical trials across 636 conditions. There are 46 research doctors associated with this hospital, such as Arun A. Rangaswami, Kieuhoa T. Vo, Hope Rugo, MD, and Jennifer G. Michlitsch.Area of expertise
1Cancer
Global LeaderStage IV
Stage III
Stage I
2Tumors
Global LeaderStage IV
Stage I
Stage III
Top PIs
Arun A. RangaswamiUCSF Medical Center-Mission Bay7 years of reported clinical research
Expert in Tumors
Expert in Cancer
29 reported clinical trials
84 drugs studied
Kieuhoa T. VoUCSF Medical Center-Mission Bay3 years of reported clinical research
Expert in Tumors
Studies Neuroblastoma
21 reported clinical trials
31 drugs studied
Hope Rugo, MDUniversity of California San Francisco4 years of reported clinical research
Expert in Breast Cancer
Studies Cancer
19 reported clinical trials
45 drugs studied
Jennifer G. MichlitschUCSF Benioff Children's Hospital Oakland7 years of reported clinical research
Studies Leukemia
Studies Lymphoblastic Leukemia-Lymphoma
22 reported clinical trials
76 drugs studied
Clinical Trials running at UCSF Medical Center-Mission Bay
Breast Cancer
Prostate Cancer
Osteosarcoma
Cancer
Brain Tumor
Ovarian Cancer
Solid Tumors
Tumors
Non-Hodgkin's Lymphoma
Pancreatic Cancer
Imlunestrant
for Early Breast Cancer
This trial is testing a new medication called imlunestrant to see if it works better than standard hormone treatments for certain breast cancer patients. The study focuses on patients with early-stage breast cancer that is estrogen receptor positive and HER2 negative, who have already been on hormone therapy for a period of time and are at high risk of their cancer returning. Imlunestrant works by blocking estrogen from helping cancer cells grow.
Recruiting2 awards Phase 36 criteria
BB-1701
for Breast Cancer
The primary purpose of the Dose Optimization (Part 1) of this study is to assess the safety and tolerability of BB-1701 and to determine the recommended dose (RD) of BB-1701 for Dose Expansion (Part 2). The primary purpose of Dose Expansion (Part 2) is to assess the antitumor activity of BB-1701 at RD in the selected population(s) of breast cancer (BC).
Recruiting1 award Phase 2
T-DM1 + Tucatinib
for Breast Cancer
This phase III trial studies how well trastuzumab emtansine (T-DM1) and tucatinib work in preventing breast cancer from coming back (relapsing) in patients with high risk, HER2 positive breast cancer. T-DM1 is a monoclonal antibody, called trastuzumab, linked to a chemotherapy drug, called DM1. Trastuzumab is a form of targeted therapy because it attaches to specific molecules (receptors) on the surface of cancer cells, known as HER2 receptors, and delivers DM1 to kill them. Tucatinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Giving T-DM1 and tucatinib may work better in preventing breast cancer from relapsing in patients with HER2 positive breast cancer compared to T-DM1 alone.
Recruiting1 award Phase 313 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at UCSF Medical Center-Mission Bay?
UCSF Medical Center-Mission Bay is a medical facility located in San Francisco, California. This center is recognized for care of Cancer, Tumors, Recurrence, Lymphoma, Brain Tumor and other specialties. UCSF Medical Center-Mission Bay is involved with conducting 382 clinical trials across 636 conditions. There are 46 research doctors associated with this hospital, such as Arun A. Rangaswami, Kieuhoa T. Vo, Hope Rugo, MD, and Jennifer G. Michlitsch.
Where is UCSF Medical Center-Mission Bay located?
**UCSF Medical Center-Mission Bay**
- **Address:** 1825 4th Street, San Francisco, CA 94158.
- **Directions:** Accessible via the Muni T-Third Street line. Exit at the UCSF Mission Bay Station on Third Street near 16th Street.
Who should I call to ask about financial aid or insurance network?
**UCSF Medical Center-Mission Bay Financial Assistance**
- For assistance with your statement balance, payment plans, or to inquire about financial aid, contact the Patient Financial Services Office at (415) 353-3333 or (866) 433-4035.
- For insurance-related questions, the Financial Counseling office is available at (415) 353-1966.
What insurance does UCSF Medical Center-Mission Bay accept?
UCSF Medical Center-Mission Bay accepts a variety of insurance plans, including PPOs, HMOs, Aetna Medicare Advantage Plans & Medicaid, HMO, POS, PPO, EPO, and several Medi-Cal plans. They have contracts with many health insurance companies, ensuring a broad coverage network. To determine your level of access to care at UCSF Health, please contact your health insurance company or employer's benefit manager.
What awards or recognition has UCSF Medical Center-Mission Bay received?
UCSF Medical Center-Mission Bay, located in San Francisco, California, is celebrated for its Magnet Recognition® for nursing excellence, showcasing over a decade of superior practices and patient care. The center is globally recognized for its pioneering research across multiple disciplines such as cardiovascular disease, neurological disorders, cancer, diabetes, genetic disorders, and immunological and infectious diseases.